Apolipoprotein E inhibition of vascular smooth muscle cell proliferation but not the inhibition of migration is mediated through activation of inducible nitric oxide synthase.
about
Human miR-221/222 in Physiological and Atherosclerotic Vascular RemodelingApolipoprotein E (apoE) isoforms differentially induce nitric oxide production in endothelial cellsThe key role of apolipoprotein E in atherosclerosis.The fat-fed apolipoprotein E knockout mouse brachiocephalic artery in the study of atherosclerotic plaque ruptureApolipoprotein E inhibition of vascular hyperplasia and neointima formation requires inducible nitric oxide synthase.An antiproliferative BMP-2/PPARgamma/apoE axis in human and murine SMCs and its role in pulmonary hypertension.Apolipoprotein E inhibits toll-like receptor (TLR)-3- and TLR-4-mediated macrophage activation through distinct mechanisms.Leukocytosis and enhanced susceptibility to endotoxemia but not atherosclerosis in adrenalectomized APOE knockout mice.Vascular apolipoprotein e expression and recruitment from circulation to modulate smooth muscle cell response to endothelial denudation.Apolipoprotein E3 Inhibits Rho to Regulate the Mechanosensitive Expression of Cox2Antimitogenic effects of HDL and APOE mediated by Cox-2-dependent IP activation.Lymphocytes are important in early atherosclerosis.Bo-Gan-Whan regulates proliferation and migration of vascular smooth muscle cellsApolipoprotein E4 impairs macrophage efferocytosis and potentiates apoptosis by accelerating endoplasmic reticulum stressNitric oxide and cell proliferation.Lipoprotein receptors--an evolutionarily ancient multifunctional receptor family.Apolipoprotein E-mediated cell cycle arrest linked to p27 and the Cox2-dependent repression of miR221/222Matrix metalloproteinases: inflammatory regulators of cell behaviors in vascular formation and remodelingApolipoprotein E enhances endothelial-NO production by modulating caveolin 1 interaction with endothelial NO synthase.Intimal hyperplasia in murine modelsApolipoprotein E4 in macrophages enhances atherogenesis in a low density lipoprotein receptor-dependent mannerMethylglyoxal and glyoxalase I in atherosclerosis.Low density lipoprotein receptor-related protein mediates apolipoprotein E inhibition of smooth muscle cell migration.Structural and functional properties of human plasma high density-sized lipoprotein containing only apoE particles.Cardiovascular protection by ApoE and ApoE-HDL linked to suppression of ECM gene expression and arterial stiffening.Inhibitory effect of recombinant iNOS gene expression on vasomotor function of canine basilar artery.Structure-function properties of the apoE-dependent COX-2 pathway in vascular smooth muscle cells.Apolipoprotein E binding to low density lipoprotein receptor-related protein-1 inhibits cell migration via activation of cAMP-dependent protein kinase A.Expression and clinical significance of apolipoprotein E in pancreatic ductal adenocarcinoma.H2O2 but not O2- elevated by oxidized LDL enhances human aortic smooth muscle cell proliferation.Effect of N-(p-coumaroyl)serotonin and N-feruloylserotonin, major anti-atherogenic polyphenols in safflower seed, on vasodilation, proliferation and migration of vascular smooth muscle cells.Human Apolipoprotein E concentration in response to diseases and therapeutic treatments
P2860
Q26801898-C2B488C3-A909-4C70-A11D-DDB580CBA191Q28189379-2FFDAA31-7F3D-44E2-BF8E-FA44552C37E9Q33213990-42D81FB8-F3CA-4101-8C76-855CDCED4F85Q34289373-26EB8F7A-99BD-4D43-8514-26242E038D56Q34537514-49A3CDD1-4700-4E50-BD88-ED07E2D1DC10Q34589929-12004B09-4612-4A64-99AB-0D2AAEAF7802Q34630303-CF1DB3FB-5019-4A20-A346-DB6800DACE41Q35050657-35A3874B-D386-43DF-92BF-E105D1940BEAQ35098355-5225BBEF-7EAB-425E-A847-2990EF527D40Q35661903-BB61FB37-3009-46C9-BB42-0F0FDE0F887CQ36056768-9AE71C86-7571-46A6-831F-8D317B0D624EQ36072647-49B8D28F-21C3-4CE4-B7D4-51D7DE3A9E65Q36109679-2BF9E6BF-611C-4EF9-BEB6-AC5783D874FCQ36201919-783DA066-B48F-4AC6-AF84-82A25991752EQ36480540-6CF9A36B-080B-4339-9134-EA79A0861B4DQ36486210-1F486B39-3C19-413B-B60E-F8B88B03FA8BQ36800668-03CDE841-5129-4A06-85A8-53FC1C491962Q36960275-22DA6830-99CE-45A6-BABC-BB328AAE1193Q37088486-7DA898CB-A5A6-469E-B376-D13A350BBCA8Q37108320-EBF6C164-5F6E-421D-807F-5A0ED56962CEQ37612769-AC0CB767-2D14-420E-93E6-3A414651763AQ38197343-8B595545-F1EF-4656-9920-BD27C0D0B512Q38294069-6FED40DB-DF32-4554-9677-48323D0D85D4Q40667270-6109277C-7065-488F-BED1-8858D44C67FAQ41929558-10862C7D-DE38-4355-AAD9-89A9FD554AB9Q42527077-826E6CAF-0538-4E01-B250-E1C47E07399FQ42541410-3091985F-1247-4CA2-AC8D-61EAC753CD56Q44511121-2E13C7B6-326A-444D-B43E-652A805AC9D7Q46553130-1EB56995-B080-44AD-8239-97CAF6A4AEA1Q51100958-02173628-6104-4ABE-BB7B-6404BFC45C49Q54584352-9F872E13-DCB6-47EE-A4F3-F63974AB48A1Q57995824-FB782CBA-76BE-4C6A-941E-9A33CB0AB303
P2860
Apolipoprotein E inhibition of vascular smooth muscle cell proliferation but not the inhibition of migration is mediated through activation of inducible nitric oxide synthase.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
Apolipoprotein E inhibition of ...... ducible nitric oxide synthase.
@en
type
label
Apolipoprotein E inhibition of ...... ducible nitric oxide synthase.
@en
prefLabel
Apolipoprotein E inhibition of ...... ducible nitric oxide synthase.
@en
P2093
P356
P1476
Apolipoprotein E inhibition of ...... ducible nitric oxide synthase.
@en
P2093
P304
P356
10.1161/01.ATV.20.4.1020
P407
P577
2000-04-01T00:00:00Z